INCR: חוב כולל להון InterCure Ltd.

InterCure Ltd. (INCR) maintains its leadership in the Israeli and European medical cannabis sector through exclusive contracts, while strict compliance shields profits from competition. However, business expansion is limited by the high resource intensity of greenhouses. This daily price chart reflects the dynamics of the separate_debt_total_eq metric, which currently stands at 0.46. High barriers to entry are driven by stringent Ministry of Health controls and the complexity of obtaining licenses.

The large-scale implementation of AI platforms and robotic control within InterCure Ltd. (INCR) logistics requires significant capital expenditures, which directly impacts the financing structure. By analyzing the debt-to-equity ratio, an investor assesses the proportion of borrowed funds to shareholders' equity, determining the degree of financial leverage and the company's solvency risks relative to its current market value.